Bioventus (BVS) Other financing activities (2020 - 2026)
Bioventus' (BVS) quarterly Other financing activities came in at -$220000.0 in Q1 2026, down 8.37% YoY from -$240107.5 in Q1 2025, and down 116.72% on a QoQ basis from $1.3 million in Q4 2025.
Bioventus (BVS) Other financing activities (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Other financing activities data on file, last reported at -$220000.0 in Q1 2026.
- Quarterly Other financing activities fell 8.37% year-over-year to -$220000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $680000.0 (down 41.38% YoY) and the FY2025 annual result came in at $697000.0, down 40.93% from the prior year.
- Other financing activities eased to -$220000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.7 million in Q4 2024 to a low of -$220000.0 in Q1 2026.
- A 5-year average of $67705.9 and a median of -$168000.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities tumbled 4400.0% — and 2024, when it soared 1113.95%.
- Tracing BVS's Other financing activities over 5 years: stood at $4000.0 in 2022, then plunged by 4400.0% to -$172000.0 in 2023, then soared by 1113.95% to $1.7 million in 2024, then fell by 24.54% to $1.3 million in 2025, then tumbled by 116.72% to -$220000.0 in 2026.
- The last three Other financing activities figures came in at -$220000.0 (Q1 2026), $1.3 million (Q4 2025), and -$207000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -241,000.00 |
| Jun 27, 2026 | -241,000.00 |
| Mar 28, 2026 | -220,000.00 |
| Mar 28, 2026 | -220,000.00 |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 27, 2025 | -207,000.00 |
| Sep 27, 2025 | -207,000.00 |
| Jun 28, 2025 | -209,000.00 |
| Jun 28, 2025 | -209,000.00 |
| Mar 29, 2025 | -203,000.00 |
| Mar 29, 2025 | -203,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 28, 2024 | -191,000.00 |
| Sep 28, 2024 | -191,000.00 |
| Jun 29, 2024 | -190,000.00 |
| Jun 29, 2024 | -190,000.00 |
| Mar 30, 2024 | -183,000.00 |
| Mar 30, 2024 | -183,000.00 |